Meeting
2012 Gastrointestinal Cancers Symposium
Staging of advanced hepatocellular carcinoma patients in the targeted therapy era.
Authors
Neeraj Nailesh Shah
University of Texas M. D. Anderson Cancer Center, Houston, TX
Neeraj Nailesh Shah , Manal Hassan , Lianchun Xiao , James L. Abbruzzese , Jeffrey Morris , Ahmed Omar Kaseb
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 209)
DOI
10.1200/jco.2012.30.4_suppl.209
Abstract #
209
Poster Bd #
B17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Evaluating the safety and efficacy of the addition of liver radiation (RT) to atezolizumab and bevacizumab (A/B) in advanced hepatocellular carcinoma (HCC): A retrospective cohort analysis.
First Author: Timothy J. Brown
Poster
2021 ASCO Annual Meeting
Comparative effectiveness of sorafenib, lenvatinib, and nivolumab as first-line systemic therapy for patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis treated at VA Medical Centers.
First Author: William Joseph Chapin
Poster
2021 Gastrointestinal Cancers Symposium
Phase II study of modulation of sorafenib (SOR)-induced autophagy using hydroxychloroquine (HCQ) in advanced hepatocellular cancer (HCC): Planned interim efficacy and safety analysis.
First Author: Sukeshi Patel Arora
Poster
2019 Gastrointestinal Cancers Symposium
Real-world treatment characteristics for first-line therapy (1L) of advanced hepatocellular carcinoma (HCC) in Canada and Europe.
First Author: Sharlene Gill